Skip to search formSkip to main contentSkip to account menu

Acapodene

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Toremifene (ACAPODENE™) Reduces High Grade Prostatic Intraepithelial Neoplasis in a Phase IIa Clinical Trial
Men with high grade prostatic intraepithelial neoplasia (HG PIN) on prostate biopsy are at high risk for prostate cancer (PCA… 
2005
2005
Mayo Study: Prostatectomy Is Best In Clinical Stage T3 Prostate Cancer
2004
2004
Toremifene citrate versus placebo for treatment of bone loss and other complications of androgen deprivation therapy in patients with prostate cancer.
4597 Background: Patients with prostate cancer receiving androgen deprivation therapy (ADT) may experience side effects including… 
Highly Cited
2003
Highly Cited
2003
Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia.
Men with high-grade prostatic intraepithelial neoplasia (PIN) evident on prostate biopsy are at high risk for the eventual… 
2003
2003
Chapter 4 – High-grade Prostatic Intraepithelial Neoplasia
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)